Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy
Authors:
- Margriet Me SchneiderMSMargriet Me Schneider
- Jan Cc BorleffsJBJan Cc Borleffs
- Ronald P StolkRSRonald P Stolk
- Christian Ajj JaspersCJChristian Ajj Jaspers
- Andy Im HoepelmanAHAndy Im Hoepelman
- 1 January 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9148) , 201-203
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Lack of Reactivation of Cytomegalovirus (CMV) Retinitis after Stopping CMV Maintenance Therapy in AIDS Patients with Sustained Elevations in CD4 T Cells in Response to Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Getting to the HAART of T cell dynamicsNature Medicine, 1998
- Effect of HAART on natural history of AIDS-related opportunistic disordersThe Lancet, 1998
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- The ups and downs of T-cell recovery in HIV-1 diseaseThe Lancet, 1997
- Therapeutic Effect of Combination Antiretroviral Therapy on Cytomegalovirus RetinitisJAMA, 1997
- Efficacy and Toxicity of Two Doses of Trimethoprim-Sulfamethoxazole as Primary Prophylaxis against Pneumocystis carinii Pneumonia in Patients with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 1995
- Clinical Manifestations of AIDS in the Era of Pneumocystis ProphylaxisNew England Journal of Medicine, 1993
- A Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992